Exendin-4

CAS No. 141732-76-5

Exendin-4( Extendin-4 )

Catalog No. M21618 CAS No. 141732-76-5

Exendin-4 is a glucagon-like protein-1 (GLP-1) receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 79 Get Quote
5MG 130 Get Quote
10MG 187 Get Quote
25MG 282 Get Quote
50MG 412 Get Quote
100MG 594 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Exendin-4
  • Note
    Research use only, not for human use.
  • Brief Description
    Exendin-4 is a glucagon-like protein-1 (GLP-1) receptor agonist.
  • Description
    Exendin-4 is a glucagon-like protein-1 (GLP-1) receptor agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Extendin-4
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    GLP-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    141732-76-5
  • Formula Weight
    4247
  • Molecular Formula
    C186H286N50O62S?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NA
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ding X Saxena N K Lin S et al. Exendin‐4 a glucagon‐like protein‐1 (GLP‐1) receptor agonist reverses hepatic steatosis in ob/ob mice[J]. Hepatology 2006 43(1).
molnova catalog
related products
  • Oxyntomodulin (porci...

    GLP-1 receptor agonist. Endogenous preproglucagon-derived neuropeptide that modulates feeding and metabolism. Also secreted by intestinal L-cells. Increases cAMP production and inhibits gastric acid secretion in rat stomach. Also weak glucagon receptor agonist.

  • GLP-1R modulator C16

    GLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4.

  • PF-06882961

    PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. PF-06882961 shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat.